Content about Allergy

August 14, 2012

Drug maker Mylan will pass out free EpiPen injectors to children in schools, the company said Tuesday.

BASKING RIDGE, N.J. — Drug maker Mylan will pass out free EpiPen injectors to children in schools, the company said Tuesday.

Mylan Specialty, the Mylan unit that makes the EpiPen (epinephrine), announced the launch of the EpiPen4Schools program. The program offers four free EpiPen or EpiPen Jr. injectors to public and private school students in kindergarten, elementary, middle and high school, who have valid prescriptions.

August 13, 2012

The Food and Drug Administration has approved a voice-guided injection device made by Sanofi for severe allergic reactions, the drug maker said Monday.

PARIS — The Food and Drug Administration has approved a voice-guided injection device made by Sanofi for severe allergic reactions, the drug maker said Monday.

The French drug maker announced the approval of Auvi-Q (epinephrine), calling it the first epinephrine auto-injector with audio and visual cues that guides users through the injection process. Sanofi US licensed the North American commercialization rights to Auvi-Q from Intelliject, which has retained commercialization rights for the rest of the world.

August 9, 2012

Four-out-of-5 seasonal allergy sufferers reported their fitness regimens suffer because they exercise less or their performance isn't as strong, according to a survey released Thursday from AllergEase.

ARLINGTON, Va. — Four-out-of-5 seasonal allergy sufferers reported their fitness regimens suffer because they exercise less or their performance isn't as strong, according to a survey released Thursday from AllergEase.

The survey also captured some of the social implications of being a seasonal allergy sufferer. Nearly 45% of people have turned down social invitations because of their seasonal allergies, the survey found, and 40% reported having had a vacation or getaway negatively affected by seasonal allergies.

August 6, 2012

The Food and Drug Administration has approved several generic versions of a drug used to treat asthma and allergies, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved several generic versions of a drug used to treat asthma and allergies, the agency said Friday.

The FDA announced the approval of montelukast sodium, a drug indicated for controlling asthma symptoms and relieving indoor and outdoor allergies.

The drug is a generic version of Merck's Singulair, which had sales of $4.6 billion in 2011, according to IMS Health.

August 1, 2012

"Buy me some peanuts and Cracker Jacks," goes the line from the famous baseball anthem. For some people, however, that innocuous lyric is a ticket to the hospital, or worse.

PITTSBURGH — "Buy me some peanuts and Cracker Jacks," goes the line from the famous baseball anthem. For some people, however, that innocuous lyric is a ticket to the hospital, or worse.

July 30, 2012

While most people treat nasal allergy symptoms, they often ignore their itchy, red, watery eyes. According to the Asthma and Allergy Foundation of America, approximately 40 million Americans have indoor/outdoor allergies as their primary allergy, and approximately 4% of allergy sufferers have eye allergies as their primary allergy. 


Already with a strong pedigree across eye care and ear care, Similasan recently launched its Kids Irritated Eye Relief for multisymptom relief from redness, burning, stinging and grittiness.

July 20, 2012

AllerMates on Thursday announced the launch of its character-driven wristbands designed for children with allergies beginning this September.

MONTVALE, N.J. — AllerMates on Thursday announced the launch of its character-driven wristbands designed for children with allergies beginning this September.

The product is introducing a clip-strip program in time for back-to-school. Retail price is $4.99 each.

AllerMates products are hypoallergenic, nickel- and latex-free, and have passed safety testing. The wristbands are adjustable and fit most children.

 

July 20, 2012

The July/August 2012 Pain Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Aleve, Advil, Bayer Advanced, Perform, Absorbine, Salonpas, Hyland's Leg Cramps ointment, Arnicare and BenGay Cold Therapy.

The July/August 2012 Pain Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Aleve, Advil, Bayer Advanced, Perform, Absorbine, Salonpas, Hyland's Leg Cramps ointment, Arnicare and BenGay Cold Therapy.

Click here for the complete guide.

July 3, 2012

Mylan has launched generic versions of two drugs to treat bipolar disorder and allergies, the company said Tuesday.

PITTSBURGH — Mylan has launched generic versions of two drugs to treat bipolar disorder and allergies, the company said Tuesday.

Mylan announced the launch of lithium carbonate extended-release tablets in the 300-mg strength. The drug is a generic version of Noven Therapeutics' Lithobid, various versions of which had sales of about $21 million during the 12-month period ended in March, according to IMS Health.

June 21, 2012

A new line of products from AllerMates is helping parents of children with allergies better protect kids against exposure to unwanted allergens.

UPPER SADDLE RIVER, N.J. — A new line of products from AllerMates is helping parents of children with allergies better protect kids against exposure to unwanted allergens. AllerMates, a line of bright, fun, whimsical character-driven wristbands, dog tags and lunch boxes feature 14 original characters that help alert teachers and caregivers to a child’s allergies.


June 21, 2012

Eye care supplements have become a big growth driver within eye care sets, and for good reason — baby boomers aren’t getting any younger and they plan to see their great grandkids play in the sandbox someday, so eye health is paramount. 


Eye care supplements have become a big growth driver within eye care sets, and for good reason — baby boomers aren’t getting any younger and they plan to see their great grandkids play in the sandbox someday, so eye health is paramount. 


May 29, 2012

The May/June 2012 Skin/Itch Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Bio-Oil, AmLactin, Cetaphil Daily Advance, Zim's Crack Creme, Olay Advanced Healing, Curel Itch Defense, Benadryl Itch Relief Spray, Cortizone 10 and Neopsporin Eczema Essentials.

The May/June 2012 Skin/Itch Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Bio-Oil, AmLactin, Cetaphil Daily Advance, Zim's Crack Creme, Olay Advanced Healing, Curel Itch Defense, Benadryl Itch Relief Spray, Cortizone 10 and Neopsporin Eczema Essentials.

Click here for the complete guide.

May 16, 2012

In contrast to the most recent cough-cold season, which was characterized by a relative lack of upper respiratory illnesses, pharmacy shoppers with itchy eyes, runny noses and audible sneezes have been back in force this spring in search of allergy relief.

In contrast to the most recent cough-cold season, which was characterized by a relative lack of upper respiratory illnesses, pharmacy shoppers with itchy eyes, runny noses and audible sneezes have been back in force this spring in search of allergy relief. And those patients are gravitating toward the OTC aisle for their seasonal allergy needs now that the last of the second-generation antihistamines was made available without a prescription a year ago. 


May 16, 2012

Optics Laboratory recently kicked off a new consumer campaign in support of its OcuFresh Eye Wash product. The product, which helps flush eye irritants like pollen, dust and smoke without perservatives, will be featured across the “Mommy Blog” circuit.


Optics Laboratory recently kicked off a new consumer campaign in support of its OcuFresh Eye Wash product. The product, which helps flush eye irritants like pollen, dust and smoke without perservatives, will be featured across the “Mommy Blog” circuit.


May 14, 2012

A company that makes an emergency treatment for severe allergic reactions is marking the 15th annual Food Allergy Awareness Week.

BASKING RIDGE, N.J. — A company that makes an emergency treatment for severe allergic reactions is marking the 15th annual Food Allergy Awareness Week.

Mylan Specialty, a division of drug maker Mylan, said it would support various initiatives to raise awareness of life-threatening food allergies during the special week, which started Sunday and ends Saturday. Mylan Specialty is the maker of EpiPen (epinephrine), used to treat anaphylaxis, a severe allergic reaction that can occur quickly and without warning.

April 6, 2012

McNeil Consumer Healthcare, the maker of Zyrtec, on Wednesday announced that actress Kate Walsh and beauty expert Rebekah George will address "allergy face" — the beauty challenges that can come along with typical allergy symptoms — during a live webcast April 10 at 8 p.m. EST on Ustream, a live interactive broadcast platform.

FORT WASHINGTON, Pa. — McNeil Consumer Healthcare, the maker of Zyrtec, on Wednesday announced that actress Kate Walsh and beauty expert Rebekah George will address "allergy face" — the beauty challenges that can come along with typical allergy symptoms — during a live webcast April 10 at 8 p.m. EST on Ustream, a live interactive broadcast platform.

April 5, 2012

Rite Aid is offering new coupon booklets and other services to help customers make it through allergy season, the retail pharmacy chain said Thursday.

CAMP HILL, Pa. — Rite Aid is offering new coupon booklets and other services to help customers make it through allergy season, the retail pharmacy chain said Thursday.

April 2, 2012

The March/April 2012 Allergy Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Claritin, Allegra, Zyrtec, Benadryl, Alavert, Advil Allergy Sinus, Chlor-Trimeton Allergy, Hyland's Seasonal Allergy Relief and Similasan Nasal Allergy Relief.

The March/April 2012 Allergy Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Claritin, Allegra, Zyrtec, Benadryl, Alavert, Advil Allergy Sinus, Chlor-Trimeton Allergy, Hyland's Seasonal Allergy Relief and Similasan Nasal Allergy Relief.

Click here for the complete guide.

March 28, 2012

A mild winter may be setting the stage for a particularly strong spring allergy season for sufferers allergic to tree pollens and mold. The incidence of seasonal allergy has been soft of late, but IMS Health is predicting a significant uptick in allergy sufferers in the coming months.

A mild winter may be setting the stage for a particularly strong spring allergy season for sufferers allergic to tree pollens and mold. The incidence of seasonal allergy has been soft of late, but IMS Health is predicting a significant uptick in allergy sufferers in the coming months.

March 26, 2012

The Food and Drug Administration has approved a drug made by Teva for treating allergies, the company said Monday.

JERUSALEM — The Food and Drug Administration has approved a drug made by Teva for treating allergies, the company said Monday.

Teva announced the approval of Qnasl (beclomethasone dipropionate) for seasonal and year-round nasal allergies in patients ages 12 years and older. The company said the drug, a "dry" nasal aerosol, would become available next month.

March 21, 2012

Optics Lab has kicked off a new consumer campaign in support of its OcuFresh Eye Wash product, the company announced Tuesday.

EL MONTE, Calif. — Optics Lab has kicked off a new consumer campaign in support of its OcuFresh Eye Wash product, the company announced Tuesday.

The product, which helps flush out such eye irritants as pollen, dust and smoke, will be featured across the "Mommy Blog" circuit and in such print publications as Prevention, Redbook and Allergies Today.

The company also is circulating a 15-second spot featured on YouTube here.

March 8, 2012

Drug maker Hi-Tech Pharmacal has bought a line of homeopathic nasal spray products from Dynova Labs, the company said Thursday.

AMITYVILLE, N.Y. — Drug maker Hi-Tech Pharmacal has bought a line of homeopathic nasal spray products from Dynova Labs, the company said Thursday.

Hi-Tech announced the acquisition of Sinus Buster and Allergy Buster for $1.25 million and an addition $1.25 million that it will deposit in an escrow account. The company also will pay Dynova a royalty on net sales for up to three and a half years or up to $1.75 million. The products, which Hi-Tech will sell through its Health Care Products over-the-counter division, had sales of $3.3 million in 2011.

March 5, 2012

A drug under development by Teva Pharmaceutical Industries appears safe and effective in treating allergies, according to results of a late-stage clinical trial released Monday.

JERUSALEM — A drug under development by Teva Pharmaceutical Industries appears safe and effective in treating allergies, according to results of a late-stage clinical trial released Monday.

Teva said a 529-patient phase-3 trial of Qnasl (beclomethasone dipropionate) nasal aerosol showed the drug produced a "significant" improvement in patients with seasonal and perennial allergies. Patients received either 320 mcg of Qnasl or a placebo.

February 24, 2012

In preparation for spring, the American College of Allergy, Asthma and Immunology on Friday noted that avoiding certain fruits and vegetables, installing the proper air filters, closing the windows, filling any allergy prescriptions and consulting with an allergist can all prevent the delay of allergy symptom relief for more than 35 million Americans who suffer from seasonal allergies.

ARLINGTON HEIGHTS, Ill. — In preparation for spring, the American College of Allergy, Asthma and Immunology on Friday noted that avoiding certain fruits and vegetables, installing the proper air filters, closing the windows, filling any allergy prescriptions and consulting with an allergist can all prevent the delay of allergy symptom relief for more than 35 million Americans who suffer from seasonal allergies.

February 17, 2012

As of the beginning of February, the cough-cold season had yet to materialize and illness levels were only just beginning to climb. If that’s the case, then an expected illness peak in late February/early March would make the 2011-2012 cough, cold and flu season one of the later-peaking seasons in recent years.


As of the beginning of February, the cough-cold season had yet to materialize and illness levels were only just beginning to climb. If that’s the case, then an expected illness peak in late February/early March would make the 2011-2012 cough, cold and flu season one of the later-peaking seasons in recent years.


As of Jan. 21, overall incidence of upper respiratory illness this season was down 7.5% according to IMS Health, as compared with the 2010-2011 season.